|
GSK3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.066000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.906800E-01 |
| Normal-vs-Stage2 |
3.630400E-02 |
| Normal-vs-Stage3 |
5.602700E-03 |
| Normal-vs-Stage4 |
2.271600E-01 |
| Stage1-vs-Stage2 |
5.328300E-02 |
| Stage1-vs-Stage3 |
1.320110E-02 |
| Stage1-vs-Stage4 |
4.966000E-01 |
| Stage2-vs-Stage3 |
9.514200E-01 |
| Stage2-vs-Stage4 |
3.396200E-01 |
| Stage3-vs-Stage4 |
2.577600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.758290E-02 |
| Normal-vs-AfricanAmerican |
8.254600E-01 |
| Normal-vs-Asian |
6.796200E-01 |
| Caucasian-vs-AfricanAmerican |
7.284100E-02 |
| Caucasian-vs-Asian |
8.646500E-02 |
| AfricanAmerican-vs-Asian |
7.416400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.261200E-03 |
| Normal-vs-Female |
9.879200E-01 |
| Male-vs-Female |
1.456430E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.513390E-01 |
| Normal-vs-Age(41-60Yrs) |
3.119000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.468200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.539840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.229000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.594600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.189200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.486550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.155160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.762200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.036300E-04 |
| Normal-vs-Grade 2 |
1.901150E-01 |
| Normal-vs-Grade 3 |
2.322200E-03 |
| Normal-vs-Grade 4 |
4.058400E-01 |
| Grade 1-vs-Grade 2 |
1.856180E-03 |
| Grade 1-vs-Grade 3 |
8.22209999999934E-05 |
| Grade 1-vs-Grade 4 |
7.619300E-03 |
| Grade 2-vs-Grade 3 |
4.814300E-02 |
| Grade 2-vs-Grade 4 |
9.324600E-01 |
| Grade 3-vs-Grade 4 |
1.409430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.568000E-01 |
| Normal-vs-ccB subtype |
1.897440E-03 |
| ccA subtype-vs-ccB subtype |
4.160200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.200230E-02 |
| Normal-vs-N1 |
6.587400E-01 |
| N0-vs-N1 |
2.830200E-01 |
|
|
